Approval · Notice of Compliance 15145 · 2014
ZOLMITRIPTAN: Notice of Compliance 15145
Issued January 21, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15145
- Date
- January 21, 2014
- Company
- Jubilant Life Sciences Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- 5-ht1 receptor agonist; migraine therapy
- Canadian reference product
- ZOMIG (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLMITRIPTAN | 02418924 | Approved |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB